CureVac N.V. Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$584.05 | Buy/Sell | $591.94 | 6.16% | 1 | $222.94B |
| DHR | Danaher | Outperform |
10
|
$262.78 | Buy/Sell | $260.33 | 3.67% | 4 | $194.64B |
| PFE | Pfizer | Outperform |
2
|
$28.88 | Buy/Sell | $32.87 | 5.61% | 6 | $163.65B |
| SAN | Sanofi | Outperform |
16
|
89.52€ | Buy/Sell | 102.80€ | 21.76% | 9 | 111.91€B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.36B |
| MRNA | Moderna | Outperform |
16
|
$166.61 | Buy/Sell | $135.42 | -24.37% | 1 | $63.85B |
| BNTX | BioNTech | Outperform |
12
|
$96.95 | Buy/Sell | $123.75 | -3.51% | 3 | $23.40B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$10.44 | Buy/Sell | HK$3.96 | -63.22% | 0 | HK$26.30B |
| TWST | Twist Bioscience | Outperform |
4
|
$42.23 | Buy/Sell | $34.00 | 6.56% | 2 | $2.40B |